APT Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,707	2,568	2,049	1,642	1,204	822.86
Other Revenue	16.41	16.41	16.62	8.49	11.55	5.82
Revenue	2,724	2,584	2,066	1,650	1,216	828.69
Revenue Growth (YoY)	25.24%	25.08%	25.18%	35.71%	46.74%	72.85%
Cost of Revenue	749.67	707.39	579.89	486.14	354.04	259.08
Gross Profit	1,974	1,877	1,486	1,164	861.98	569.61
Selling, General & Admin	598.24	579.25	464.34	386.96	307.57	251.43
Research & Development	386.21	364.8	290.54	237.92	174.88	134.88
Other Operating Expenses	31.72	28.18	15.22	14.52	13.75	8.14
Operating Expenses	1,030	988.53	772.32	639.21	496.99	393.93
Operating Income	944.49	888.01	713.59	524.86	364.99	175.68
Interest Expense	-0.82	-1.46	-2.01	-3.69	-1.45	-1.63
Interest & Investment Income	34.76	30.73	25.23	27.74	23.94	13.26
Currency Exchange Gain (Loss)	-5.3	-5.3	2.83	2.66	1.17	-1
Other Non Operating Income (Expenses)	-6.73	-0.83	-0.82	-0.04	-0.49	-0.5
EBT Excluding Unusual Items	966.41	911.16	738.83	551.53	388.16	185.81
Impairment of Goodwill	-	-	-	-3.84	-	-
Gain (Loss) on Sale of Investments	1.49	0.49	-16.7	-	0.34	21.72
Gain (Loss) on Sale of Assets	-1.26	-0.93	0.25	11.97	0.06	0.02
Asset Writedown	-5.95	-1.85	-0.83	-0.12	-10.68	-3.57
Other Unusual Items	27.31	27.43	24.42	36.83	17.25	17.58
Pretax Income	988	936.29	745.97	596.37	395.13	221.55
Income Tax Expense	134.63	128.55	87.8	74.24	54.98	26.7
Earnings From Continuing Operations	853.37	807.74	658.17	522.13	340.16	194.85
Minority Interest in Earnings	13.56	12.9	14.98	11.79	17.86	13.07
Net Income	866.92	820.64	673.15	533.92	358.02	207.92
Net Income to Common	866.92	820.64	673.15	533.92	358.02	207.92
Net Income Growth	21.05%	21.91%	26.08%	49.13%	72.19%	87.70%
Shares Outstanding (Basic)	141	141	140	140	140	137
Shares Outstanding (Diluted)	141	141	141	142	142	138
Shares Change (YoY)	0.07%	0.05%	-0.27%	-0.16%	2.99%	31.45%
EPS (Basic)	6.16	5.82	4.80	3.82	2.56	1.52
EPS (Diluted)	6.13	5.80	4.76	3.77	2.52	1.51
EPS Growth	20.97%	21.85%	26.41%	49.38%	67.20%	42.79%
Free Cash Flow	702.29	682.17	93.15	487.03	224.25	14.01
Free Cash Flow Per Share	4.96	4.82	0.66	3.44	1.58	0.10
Dividend Per Share	1.000	1.000	1.207	0.951	0.785	0.476
Dividend Growth	-17.14%	-17.14%	26.88%	21.20%	65.01%	100.00%
Gross Margin	72.48%	72.62%	71.93%	70.54%	70.88%	68.74%
Operating Margin	34.68%	34.37%	34.54%	31.81%	30.01%	21.20%
Profit Margin	31.83%	31.76%	32.58%	32.36%	29.44%	25.09%
Free Cash Flow Margin	25.78%	26.40%	4.51%	29.51%	18.44%	1.69%
EBITDA	1,051	988.48	790.98	580.9	405.69	203.49
EBITDA Margin	38.58%	38.26%	38.29%	35.20%	33.36%	24.56%
D&A For EBITDA	106.25	100.47	77.38	56.04	40.7	27.81
EBIT	944.49	888.01	713.59	524.86	364.99	175.68
EBIT Margin	34.68%	34.37%	34.54%	31.80%	30.01%	21.20%
Effective Tax Rate	13.63%	13.73%	11.77%	12.45%	13.91%	12.05%
Revenue as Reported	2,724	2,584	2,066	1,650	1,216	828.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.